Literature DB >> 15699539

Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in healthy men.

Blandine Laferrère1, Cynthia Abraham, Colleen D Russell, Cyril Y Bowers.   

Abstract

GHRP-2 is a synthetic agonist of ghrelin, the newly-discovered gut peptide which binds to the growth hormone (GH) secretagogue receptor. Ghrelin has two major effects, stimulating both GH secretion and appetite/meal initiation. GHRP-2 has been extensively studied for its utility as a growth hormone secretagogue (GHS). Animal studies have shown its effect on food intake. However, whether GHRP-2 can also stimulate appetite in humans when administered acutely is not known. We subcutaneously infused 7 lean, healthy males with GHRP-2 (1 microg/kg/h) or saline for 270 minutes and then measured their intake of an ad libitum, buffet-style meal. Similar to what has been reported for ghrelin administration, our subjects ate 35.9 +/- 10.9% more when infused with GHRP-2 vs. saline, with every subject increasing their intake even when calculated per kg body weight (136.0 +/- 13.0 kJ/kg [32.5 +/- 3.1 kcal/kg] vs. 101.3 +/- 10.5 kJ/kg [24.2 +/- 2.5 kcal/kg], p = 0.008). The macronutrient composition of consumed food was not different between conditions. As expected, serum GH levels rose significantly during GHRP-2 infusion (AUC 5550 +/- 1090 microg/L/240 min vs. 412 +/- 161 microg/L/240 min, p = 0.003). These data are the first to demonstrate that GHRP-2, like ghrelin, increases food intake, suggesting that GHRP-2 is a valuable tool for investigating ghrelin effects on eating behavior in humans.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15699539      PMCID: PMC2824650          DOI: 10.1210/jc.2004-1719

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  33 in total

Review 1.  Growth hormone secretagogue actions on the pituitary gland: multiple receptors for multiple ligands?

Authors:  C Chen
Journal:  Clin Exp Pharmacol Physiol       Date:  2000 May-Jun       Impact factor: 2.557

2.  Intracerebroventricular administration of the growth hormone-releasing peptide KP-102 increases food intake in free-feeding rats.

Authors:  K Okada; S Ishii; S Minami; H Sugihara; T Shibasaki; I Wakabayashi
Journal:  Endocrinology       Date:  1996-11       Impact factor: 4.736

3.  Ghrelin induces adiposity in rodents.

Authors:  M Tschöp; D L Smiley; M L Heiman
Journal:  Nature       Date:  2000-10-19       Impact factor: 49.962

4.  A role for ghrelin in the central regulation of feeding.

Authors:  M Nakazato; N Murakami; Y Date; M Kojima; H Matsuo; K Kangawa; S Matsukura
Journal:  Nature       Date:  2001-01-11       Impact factor: 49.962

5.  Ghrelin strongly stimulates growth hormone release in humans.

Authors:  K Takaya; H Ariyasu; N Kanamoto; H Iwakura; A Yoshimoto; M Harada; K Mori; Y Komatsu; T Usui; A Shimatsu; Y Ogawa; K Hosoda; T Akamizu; M Kojima; K Kangawa; K Nakao
Journal:  J Clin Endocrinol Metab       Date:  2000-12       Impact factor: 5.958

6.  A 6-day intracerebroventricular infusion of the growth hormone-releasing peptide KP-102 stimulates food intake in both non-stressed and intermittently-stressed rats.

Authors:  H Kuriyama; M Hotta; I Wakabayashi; T Shibasaki
Journal:  Neurosci Lett       Date:  2000-03-17       Impact factor: 3.046

7.  Pharmacokinetics and pharmacodynamics of growth hormone-releasing peptide-2: a phase I study in children.

Authors:  C Pihoker; G L Kearns; D French; C Y Bowers
Journal:  J Clin Endocrinol Metab       Date:  1998-04       Impact factor: 5.958

8.  The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion.

Authors:  A M Wren; C J Small; H L Ward; K G Murphy; C L Dakin; S Taheri; A R Kennedy; G H Roberts; D G Morgan; M A Ghatei; S R Bloom
Journal:  Endocrinology       Date:  2000-11       Impact factor: 4.736

9.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

Authors:  M Kojima; H Hosoda; Y Date; M Nakazato; H Matsuo; K Kangawa
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

10.  A receptor in pituitary and hypothalamus that functions in growth hormone release.

Authors:  A D Howard; S D Feighner; D F Cully; J P Arena; P A Liberator; C I Rosenblum; M Hamelin; D L Hreniuk; O C Palyha; J Anderson; P S Paress; C Diaz; M Chou; K K Liu; K K McKee; S S Pong; L Y Chaung; A Elbrecht; M Dashkevicz; R Heavens; M Rigby; D J Sirinathsinghji; D C Dean; D G Melillo; A A Patchett; R Nargund; P R Griffin; J A DeMartino; S K Gupta; J M Schaeffer; R G Smith; L H Van der Ploeg
Journal:  Science       Date:  1996-08-16       Impact factor: 47.728

View more
  12 in total

Review 1.  The Safety and Efficacy of Growth Hormone Secretagogues.

Authors:  John T Sigalos; Alexander W Pastuszak
Journal:  Sex Med Rev       Date:  2017-04-08

Review 2.  Anorexia in cancer: role of feeding-regulatory peptides.

Authors:  Simona Perboni; Akio Inui
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

3.  Obese subjects respond to the stimulatory effect of the ghrelin agonist growth hormone-releasing peptide-2 on food intake.

Authors:  Blandine Laferrère; Allison B Hart; Cyril Y Bowers
Journal:  Obesity (Silver Spring)       Date:  2006-06       Impact factor: 5.002

4.  Effect of weight loss by diet or gastric bypass surgery on peptide YY3-36 levels.

Authors:  Blanca Oliván; Julio Teixeira; Mousumi Bose; Baani Bawa; Tangel Chang; Heather Summe; Hongchan Lee; Blandine Laferrère
Journal:  Ann Surg       Date:  2009-06       Impact factor: 12.969

5.  Long-term effects of ghrelin and ghrelin receptor agonists on energy balance in rats.

Authors:  Sabine Strassburg; Stefan D Anker; Tamara R Castaneda; Lukas Burget; Diego Perez-Tilve; Paul T Pfluger; Ruben Nogueiras; Heather Halem; Jesse Z Dong; Michael D Culler; Rakesh Datta; Matthias H Tschöp
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-05-06       Impact factor: 4.310

Review 6.  Pharmacological Modulation of Ghrelin to Induce Weight Loss: Successes and Challenges.

Authors:  Martha A Schalla; Andreas Stengel
Journal:  Curr Diab Rep       Date:  2019-09-10       Impact factor: 4.810

7.  Growth hormone releasing peptide 2 reverses anorexia associated with chemotherapy with 5-fluoruracil in colon cancer cell-bearing mice.

Authors:  Simona Perboni; Cyril Bowers; Shinya Kojima; Akihiro Asakawa; Akio Inui
Journal:  World J Gastroenterol       Date:  2008-11-07       Impact factor: 5.742

Review 8.  The multiple faces of glucagon-like peptide-1--obesity, appetite, and stress: what is next? A review.

Authors:  Eldo E Frezza; Mitchell S Wachtel; Maurizio Chiriva-Internati
Journal:  Dig Dis Sci       Date:  2007-03       Impact factor: 3.487

9.  Potentiation of ghrelin signaling attenuates cancer anorexia-cachexia and prolongs survival.

Authors:  N Fujitsuka; A Asakawa; Y Uezono; K Minami; T Yamaguchi; A Niijima; T Yada; Y Maejima; U Sedbazar; T Sakai; T Hattori; Y Kase; A Inui
Journal:  Transl Psychiatry       Date:  2011-07-26       Impact factor: 6.222

10.  One-year intranasal application of growth hormone releasing peptide-2 improves body weight and hypoglycemia in a severely emaciated anorexia nervosa patient.

Authors:  Izumi Haruta; Yuki Fuku; Kazuhisa Kinoshita; Koichi Yoneda; Akinori Morinaga; Marie Amitani; Haruka Amitani; Akihiro Asakawa; Hideki Sugawara; Yasuo Takeda; Cyril Y Bowers; Akio Inui
Journal:  J Cachexia Sarcopenia Muscle       Date:  2015-04-27       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.